CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Karyopharm Therapeutics granted an aggregate of 1,850 restricted stock units to two newly-hired employees under Nasdaq Listing Rule 5635(c)(4) inducement grant provisions.

Importance:2/10
Sentiment:
0.00
inducement grantsRSUsemployee compensationNASDAQ listing rule
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 1, 2026 8:05 PM

Read Original